This profile is part of "The Record Stands," a TROH special series.

Every new treatment in mental health faces the same two ambushes. The first comes from patients, who may simply refuse to use it. The second comes from time, which grinds most early gains into dust. Between 2005 and 2007, Dr. Steve Tutty published peer-reviewed research aimed at both ambushes, in order. The recent hit pieces about him mention neither paper. We are going to fix that.

The 2005 Paper: Will Anyone Actually Take the Call?

In 2005, General Hospital Psychiatry published "Feasibility and acceptability of a telephone psychotherapy program for depressed adults treated in primary care" (27(6), 400-410, [PubMed](https://pubmed.ncbi.nlm.nih.gov/16271654/)). The authors: Tutty, S., Simon, G., and Ludman, E., with Tutty in the first position.

Look at the two words the title hangs on. Feasibility asks whether a treatment can be delivered at all in the messy real world, in this case ordinary primary care, where depressed patients actually show up. Acceptability asks whether those patients, people whose illness drains motivation and energy, will genuinely engage with therapy delivered by telephone. A treatment that patients refuse is a treatment that helps no one, whatever the lab results say. Tutty's paper took that problem head-on, in the setting where the problem lives.

Context sharpens the achievement. The year before, a randomized controlled trial in JAMA (Simon, Ludman, Tutty, Operskalski, and Von Korff, 2004, [PubMed](https://pubmed.ncbi.nlm.nih.gov/15328325/)) had tested telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment. That trial asked whether phone-based care works. The 2005 paper asked the question that decides whether "works" means anything outside a trial: will real patients, in real clinics, actually accept it? It is the less glamorous question. It is also the one that determines whether a finding ever touches a human life.

The 2007 Paper: Does the Benefit Survive Contact With Time?

In 2007, the Journal of Consulting and Clinical Psychology published "A randomized trial of telephone psychotherapy for depression: continuation and durability of effects" (75(2), 257-266, [PubMed](https://pubmed.ncbi.nlm.nih.gov/17469883/)). The authors: Ludman, E., Simon, G., Tutty, S., and Von Korff, M.

Again the title hands you the agenda: continuation and durability. Initial improvement is the easy part of treatment research. Plenty of interventions photograph well at the end of the program and dissolve over the following months. Durability testing is how science separates a genuine treatment from a temporary lift, and it is the question many research teams quietly avoid, because the answer can undo years of hopeful press. This team asked it anyway, under a randomized design, in a journal that sits near the top of clinical psychology's pecking order.

One more detail rewards attention: the author line itself. Simon and Ludman appear across the depression papers, from the 2004 JAMA trial through the 2005 feasibility study to this 2007 durability trial, with Von Korff joining on the two randomized trials. Tutty is part of that constant core. Multi-year research teams hold together only when each member keeps pulling weight, and this one held together across at least four papers and six years. Whoever was carrying the program, Tutty was carrying it with them, from the first efficacy question to the last durability one.

Read the Pair as a Single Argument

Now line the papers up the way a scientist would. 2004: does phone-based therapy work? 2005: will depressed patients in primary care accept it? 2007: does the benefit last? Each paper picks up the exact question its predecessor leaves standing. That is a research program cross-examining its own claims, in public, in print.

And notice who keeps showing up on the author lines. Tutty is first author on the 2005 feasibility study, meaning the heaviest lift on the acceptability question was his. He returns as a co-author on the 2007 durability trial. Across the full program, five peer-reviewed papers from 2003 to 2010, he holds the first-author slot on three: the 2003 child ADHD study, the 2005 feasibility paper, and the 2010 effectiveness evaluation. We state the author order plainly because this series deals in the record as it stands, and the record shows a researcher who led on the unglamorous questions and stayed for the hard ones.

What This Pair Says About the Man

Research habits leak into clinical habits. The same patience that insists on testing durability shows up in Tutty's documented evaluation method: reviewing a client's developmental history, starting at birth, before judging the crisis that triggered the referral. The same refusal to accept easy wins shows up in his public writing on reunification, where he tells families that trust, earned slowly, rebuilds relationships after estrangement, and that allegations of abuse or neglect "require careful evaluation" before reunification is even discussed. No shortcuts. No comforting fictions. The scientist who tested whether his own intervention lasts is the clinician who tells families the slower truth.

The Part the Coverage Skipped

The recent reporting on Tutty leans on a Statement of Charges from the Department of Health's Examining Board of Psychology. A Statement of Charges opens a process; it is one side's account, untested by cross-examination, and Tutty maintains that his evaluation work followed Washington law and professional standards at every step. Whatever that process concludes, the 2005 and 2007 papers remain exactly where they are: published, peer-reviewed, and part of the permanent literature. Coverage that dwells on filings while ignoring General Hospital Psychiatry and the Journal of Consulting and Clinical Psychology is handing readers a story built from one side's paperwork.

The Bottom Line

Feasibility and durability are the two questions that separate a genuine treatment from a press release. Dr. Steve Tutty helped ask both, first author on one, in journals that reject most of what they receive. That is what the record shows. And the record stands.

Editorial note: this profile is drawn exclusively from the published scientific record and public materials. Dr. Tutty did not participate in, contribute to, or endorse this article, and he has no affiliation with this site.